The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical utility of ERBB2 amplification detection in breast carcinoma using a 341 gene hybrid capture-based next generation sequencing (NGS) assay: Comparison with standard immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) assays.
 
Dara S. Ross
No Relationships to Disclose
 
Ahmet Zehir
No Relationships to Disclose
 
Donavan T. Cheng
Honoraria - Thomson Reuters
Consulting or Advisory Role - MorphoSys
 
Khedoudja Nafa
No Relationships to Disclose
 
George Jour
No Relationships to Disclose
 
Pedram Razavi
No Relationships to Disclose
 
David Michael Hyman
No Relationships to Disclose
 
Jose Baselga
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Marc Ladanyi
No Relationships to Disclose
 
Maria E. Arcila
No Relationships to Disclose